Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 2
2005 6
2006 3
2007 4
2008 2
2009 4
2010 5
2011 7
2012 8
2013 7
2014 13
2015 15
2016 17
2017 19
2018 18
2019 13
2020 24
2021 18
2022 20
2023 12
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
Bianchi A, Cortese R, Prados F, Tur C, Kanber B, Yiannakas MC, Samson R, De Angelis F, Magnollay L, Jacob A, Brownlee W, Trip A, Nicholas R, Hacohen Y, Barkhof F, Ciccarelli O, Toosy AT. Bianchi A, et al. Among authors: nicholas r. Mult Scler. 2024 May;30(6):674-686. doi: 10.1177/13524585241240420. Epub 2024 Apr 22. Mult Scler. 2024. PMID: 38646958
Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis.
Cencioni MT, Magliozzi R, Palmisano I, Suwan K, Mensi A, Fuentes-Font L, Villar LM, Fernández-Velasco JI, Migallón NV, Costa-Frossard L, Monreal E, Ali R, Romozzi M, Mazarakis N, Reynolds R, Nicholas R, Muraro PA. Cencioni MT, et al. Among authors: nicholas r. J Neuroinflammation. 2024 Apr 12;21(1):91. doi: 10.1186/s12974-024-03077-9. J Neuroinflammation. 2024. PMID: 38609999 Free PMC article.
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M, Battaglini M, De Stefano N, Di Filippo M, Hametner S, Howell OW, Inglese M, Lassmann H, Martin R, Nicholas R, Reynolds R, Rocca MA, Tamanti A, Vercellino M, Villar LM, Filippi M, Magliozzi R. Calabrese M, et al. Among authors: nicholas r. Ann Neurol. 2024 Apr 3. doi: 10.1002/ana.26913. Online ahead of print. Ann Neurol. 2024. PMID: 38568026 Review.
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O, Coles AJ, Cooper C, Giovannoni G, Gabriel I, Kazmi M, Kyriakou C, Nicholas R, Paling D, Peniket A, Scolding N, Silber E, de Silva T, Venneri A, Walters SJ, Young C, Muraro PA, Sharrack B, Snowden JA; StarMS trial team. Brittain G, et al. Among authors: nicholas r. BMJ Open. 2024 Feb 5;14(2):e083582. doi: 10.1136/bmjopen-2023-083582. BMJ Open. 2024. PMID: 38316583 Free PMC article.
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
Herranz E, Treaba CA, Barletta VT, Mehndiratta A, Ouellette R, Sloane JA, Ionete C, Babu S, Mastantuono M, Magon S, Loggia ML, Makary MM, Hooker JM, Catana C, Kinkel R, Nicholas R, Klawiter EC, Magliozzi R, Mainero C. Herranz E, et al. Among authors: nicholas r. Brain. 2024 Jan 30:awae030. doi: 10.1093/brain/awae030. Online ahead of print. Brain. 2024. PMID: 38289855
Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple Sclerosis.
Knowles S, Middleton R, Cooze B, Farkas I, Leung YY, Allen K, Winslade M, Owen DRJ, Magliozzi R, Reynolds R, Neal JW, Pearson O, Nicholas R, Pickrell WO, Howell OW; UK MS Register Research Group. Knowles S, et al. Among authors: nicholas r. Ann Neurol. 2024 Mar;95(3):471-486. doi: 10.1002/ana.26843. Epub 2023 Dec 22. Ann Neurol. 2024. PMID: 38061895
Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.
Young CA, Rog DJ, Sharrack B, Tanasescu R, Kalra S, Harrower T, Tennant A, Mills RJ; Trajectories of Outcome in Neurological Conditions-MS Study Group. Young CA, et al. Neurol Sci. 2024 May;45(5):2181-2189. doi: 10.1007/s10072-023-07155-3. Epub 2023 Nov 17. Neurol Sci. 2024. PMID: 37976012 Free PMC article.
206 results